FIGURE 2: The effect of nitrous oxide on vitamin B 12, a coenzyme for methionine synthetase, leading to impaired deoxythymidine production and hyperhomocysteinaemia.
Nitrous Oxide and Anaesthesia
In 1844, a dentist named Horace Wells attended a public demonstration of nitrous oxide (N 2 O), after seeing an advertisement stating "Those who inhale the gas once, are always anxious to inhale the second time ... No language can describe the delightful sensation produced ..." 1 . Later, Wells had one of his own teeth extracted by a fellow dentist under N 2 O and was so impressed that he experimented on many patients before demonstrating his new finding at Harvard University. Although this was a failure -"a humbug" -N 2 O anaesthesia rapidly became popular throughout much of the world. Unlike the fate of other anaesthetic gases subsequently introduced, such as chloroform and ether, N 2 O still has a central role in current anaesthetic practice 2 . Despite some authoritative opinions to the contrary 1,3 , a recent survey of anaesthetists in Great Britain found that 82% used N 2 O frequently and 80% felt that it should remain freely available for use on anaesthetic machines 2 . There are about two million anaesthetics given each year in Australia 4 , about half of which can be expected to include N 2 O. A re-appraisal of the potential risks and benefits of N 2 O therefore is indicated.
N 2 O has a number of known side-effects 1, 3, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] , yet is a cheap, widely available and well-known adjunct to general anaesthesia. Most anaesthetists consider it has a very good safety profile, but its relative merits have yet to be tested in a large trial of effectiveness in anaesthetic practice. N 2 O has limited potency, with a minimum alveolar concentration of 104%. N 2 O anaesthesia cannot prevent intraoperative recall reliably 15 . Thus it is unable to provide anaesthesia as a sole agent. The usual practice is to administer 60% to 70% N 2 O in oxygen along with an inhalational agent or propofol in order to produce a depth of anaesthesia sufficient for surgery. N 2 O increases the speed of induction of anaesthesia by a "second gas effect" 1 . This is of theoretical benefit during inhalational anaesthesia, but in practice simple overpressure with volatile agent in the first few minutes of anaesthesia is used by most anaesthetists to achieve a similar result. Early studies clearly demonstrated that N 2 O produces dose-related analgesia in humans, thereby ablating potentially harmful responses such as tachycardia and movement. Current anaesthetic practice usually includes N 2 O, allowing a dose-reduction of other anaesthetic, opioid, and possibly muscle relaxant drugs, administered during surgery.
The prevailing view is that N 2 O is a cheap, relatively "safe" drug that can reduce exposure to other anaesthetic drugs. However, in a recent commentary, Stenqvist and colleagues 3 outlined the history of N 2 O and explored its place in modern anaesthesia. They concluded, partly because of the availability and effectiveness of modern drugs, that N 2 O should be "retired" from use. A similar opinion was expressed by Eger in 1983 1 . The arguments for and against the continued use of N 2 O are summarized ( Figure 1 ).
Adverse Effects of N 2 O
N 2 O interferes with vitamin B 12 and folate metabolism, by oxidizing the cobalt atom and irreversibly inactivating the enzyme methionine synthetase 5, 6, 11 . This impairs production of methionine (from homocysteine), a substrate for tetrahydrofolate and thymidine during DNA synthesis ( Figure 2 ). These adverse effects are time-exposure dependent and are probably greater in elderly and unwell patients 5, 8, 16, 17 . A twohour exposure to N 2 O is associated with a 50% reduction in methionine synthetase activity 5 , raising the possibility of adverse effects such as immunodeficiency and impaired wound healing. It is wellknown that N 2 O-induced vitamin B 12 and folate deficiency can lead to a clinical syndrome similar to pernicious anaemia, manifesting as megaloblastic anaemia and subacute combined degeneration of the spinal cord [8] [9] [10] [11] [12] [13] [14] 18 .
Megaloblastic anaemia
Unrecognised vitamin B 12 and folate deficiency are reasonably common in the community, particularly in the elderly and vegan populations 8, 10, 16, 17, 19, 20 . We therefore may be putting many patients at risk of post-operative megaloblastic anaemia by exposing them to N 2 O. The inhibitory effect of N 2 O on methionine synthetase and DNA synthesis can be assessed by the deoxyuridine (dU) suppression test. Amos and coworkers 17 , in a prospective study of 70 seriously ill patients admitted to an intensive-care unit, identified megaloblastic bone-marrow change in 22 patients on admission, of whom 18 had been anaesthetized with N 2 O for less than six hours during surgery. Sixteen of these 18 patients died, compared with seven of 22 patients who were normoblastic despite receiving equivalent amounts of N 2 O. An abnormal dUsuppression test only developed in patients who had received N 2 O; and on admission an abnormal dUsuppression test was found in 39 of the 42 patients who had been exposed to N 2 O. Similarly, Deleu and co-workers 16 randomized 69 elderly patients undergoing eye surgery to receive general anaesthesia with or without N 2 O. They reported a significant decrease in serum folate and a significant increase in mean red cell volume. Three of the N 2 O-exposed patients developed symptoms of folate deficiency.
The inhibition of methionine synthetase by N 2 O can be rapid and long-lasting. Exposure beyond a few hours will reduce methionine synthetase activity by 50% and 12 to 24 hours of exposure will result in marked megaloblastic changes. These effects have been reported in critically ill patients 17 and those with sickle cell disease 13 , and may be partly avoided with large doses of vitamin B 12 or folic acid. A propensity to anaemia may increase blood transfusion requirements, a risk factor for postoperative sepsis and other morbidity 21 .
Immunosuppression
Surgery and anaesthesia compromise host defence mechanisms by depressing specific and non-specific components of the immune response. Those with preexisting disease undergoing major surgery are most at risk. N 2 O inhibits the lymphocytic response 22 and cellmediated cytotoxicity 23 . The chemotactic migration of monocytes and neutrophils is more significantly depressed by N 2 O than by other anaesthetic agents 24 . The reversible leukopaenic and granulocytopaenic effects seen after long-term exposure to N 2 O in both animal models and humans 25 are consistent with the histological changes seen in bone marrow due to im-pairment of methionine production, DNA synthesis and mitosis. Cellular adenosine triphosphate levels fall after six hours of exposure to N 2 O 26 , leading to compromise of alveolar macrophage viability and function. Despite these laboratory studies, outcome studies have not been performed and so we are uncertain whether N 2 O-induced immunosuppression is of clinical importance.
In a randomized controlled trial of 500 patients undergoing colorectal surgery, Greif and co-workers 27 compared 80% oxygen (in nitrogen) with 30% oxygen (in nitrogen). They found a marked reduction in the incidence of wound infection (11% vs 5%; P=0.01), suggesting that supplemental oxygen is antimicrobial. The use of N 2 O prevents the administration of high oxygen concentrations (>80%) and therefore may further contribute to increased wound infection rates and a longer duration of hospital stay.
Homocysteine and myocardial ischaemia
N 2 O-induced inactivation of methionine synthetase increases plasma homocysteine concentrations after surgery 7, 19, 28 . A recent study has shown that plasma concentrations of homocysteine do not return to normal for at least one week after surgery and N 2 O-based anaesthesia 19 .
Long-term elevation of plasma concentrations of homocysteine is an independent risk factor for coronary artery and cerebrovascular disease 29, 30 , and acute increases cause endothelial dysfunction 31 and hypercoaguability 32 . Thus, N 2 O may be a risk factor for postoperative myocardial ischaemia. In a recent randomized trial, Badner and co-workers 7 allocated 90 patients to anaesthesia with or without N 2 O. The N 2 O group had significantly increased plasma homocysteine concentrations and a higher incidence of myocardial ischaemia (46% vs 25%; P<0.05), more ischaemic events in total (82 vs 53; P<0.02), and more ischaemic events lasting 30 minutes (23 vs 14; P<0.05). This is a particularly relevant finding, as the incidence of myocardial ischaemia is highest in the hours after surgery, and this is strongly associated with postoperative myocardial infarction.
Postoperative nausea and vomiting
Postoperative nausea and vomiting is the most common complication of surgery and anaesthesia, affecting up to 40% of patients. Postoperative nausea and vomiting is a major source of patient dissatisfaction 33 , delays recovery after anaesthesia and surgery, and possibly hospital discharge. Level 1 evidence from a meta-analysis of 2478 patients in 24 randomized controlled trials found that avoidance of N 2 O significantly reduced the incidence of PONV 34 . The number-needed-to-treat (NNT) in a higher-risk group was 5 (95% CI: 4-10). Avoidance of N 2 O also allows supplemental oxygen to be given, which of itself has been shown to reduce the incidence of postoperative nausea and vomiting 27 . In a randomized controlled trial of 231 patients 35 , use of 80% oxygen was associated with a 43% reduction in early (<24 h) PONV (30% vs 17%; P=0.02). Thus, N 2 O is a potent cause of PONV and may be associated with delayed ambulation after surgery, reduced food intake, increased postoperative complications and prolonged hospital stay.
Nerve and spinal cord toxicity
Subacute combined degeneration of the cord was first reported in critically ill patients chronically sedated with N 2 O 14 , a practice now obsolete. Nevertheless, there have been reports of serious nerve damage and paraplegia in humans with repeated exposure of N 2 O 8, 9, 17, 18, 36 , including with a short period of only 65 minutes 9 . Subclinical folate and vitamin B 12 deficiency, common in elderly patients undergoing many types of surgery, may be a precipitating factor 8 .
Recent evidence suggests that N 2 O is an antagonist at N-methyl-D-aspartate (NMDA) receptors 6, 37 , explaining at least some of its central effects. Another NMDA antagonist, selfotel, has been shown to be neurotoxic in head injury patients 37 . This may be another mechanism by which N 2 O can result in postoperative neuropathy 8, 9, 37 .
Carcinogenicity, teratogenicity, and occupational exposure
The inhibition of methionine synthetase by N 2 O leads to deficiency in thymidine, impairing DNA production and possibly organogenesis. Other mechanisms may also be involved 6 . N 2 O is the only inhaled anaesthetic proven to be teratogenic in animals 39 , with increased rates of foetal reabsorptions and visceral and skeletal abnormalities. In 1978 Vessey 40 , in a review of the evidence, concluded that "there is ... reasonably convincing evidence of a moderate increase in the risk of spontaneous abortion among females, although it is possible that even this result is attributable to reporting bias". A subsequent well conducted large study by Rowland and co-workers 41 found reduced fertility among dental assistants exposed to N 2 O. Moreover, a recent meta-analysis found strong evidence of increased rates of spontaneous abortion in women occupationally exposed to N 2 O 42 . The overall relative risk was 1.48 (95% CI: 1.4-1.6). The estimate of risk increased to 1.9 (95% CI: 1.7-2.1) when analysis was restricted to studies rated the most rigorous by the reviewers. Since then, a Swedish survey of midwives exposed to N 2 O found a significant risk to them of low birthweight infants and infants small for gestational age (odds ratio: 1.8 [95% CI: 1.1-2.8]) 43 .
Occupational exposure to trace anaesthetic gases, and in particular N 2 O, is routine 43, 44 . Leaks occur around the mask (40%), unconnected scavenging systems (19%), uncuffed endotracheal tubes (13%), equipment (12%) and other sites (16%) 43 . For example, Jenstrup and colleagues 45 reported that during facemask anaesthesia, a concentration of N 2 O above 100 ppm was found during 51% of the exposure time compared with 24% of the time during laryngeal mask anaesthesia. With occupational exposure to N 2 O being common, and possibly harmful, the burden of proof of its safety should be set at a higher level than the traditional "statistically significant" 5% level.
Hypoxia
In the past, there were reports of oxygen delivery failure or inadvertent delivery of hypoxic gas mixtures in the setting of N 2 O administration, resulting in severe hypoxic brain damage or death. Modern standards for the design of anaesthetic machines demand the inclusion of anti-hypoxic devices to flowmeter banks to prevent delivery of hypoxic mixtures, but this adds to the cost and complexity of this equipment. Cylinders, pipelines and valves require regular maintenance, and may malfunction. Thus, provision of high-pressure N 2 O supply comes at substantial cost. Piped gas supplies may malfunction or be "crossed", resulting in hypoxic mixtures being delivered throughout the hospital. These risks are partly mitigated by the routine use of oxygen analysers and pulse oximetry. Higher inspired fractions of oxygen (i.e. without N 2 O) increase tissue oxygen tension, thereby increasing the time before hypoxia develops following a critical incident. At the end of surgery, when N 2 O administration is ceased, there is a rapid movement of N 2 O into the alveolar space. This reduces alveolar oxygen concentration, and may produce diffusion hypoxia 46 .
Air spaces
The solubility of N 2 O is 34 times that of nitrogen (the major component of air), with the blood:gas partition coefficients being 0.46 and 0.015 respectively 1 , so N 2 O will diffuse rapidly into closed air spaces. If the air space is compliant (e.g. air embolus, pneumothorax, distended bowel, lung bullae) there will be a volume expansion, and if non-compliant (e.g. sinuses, middle ear post-tympanic surgery, intracranial air) there will be an increase in pressure. The time course can be impressive, with an air space volume enlarging twofold in 10 minutes and threefold in 45 minutes 47 . There have been many recent reports of patient blindness within weeks of vitreoretinal surgery that included intraocular perfluoropropane 12 -the N 2 O-induced expansion of air space led to retinal artery occlusion and optic atrophy. N 2 O should not be given if a gas embolism or pneumothorax is suspected, and is contraindicated in bowel obstruction or within 30 days of vitreoretinal surgery.
Adverse circulatory effects
N 2 O can increase pulmonary artery pressure 47 , and is relatively contraindicated for patients with pulmonary hypertension. N 2 O also activates the sympathetic nervous system and can sensitize the myocardium to the arrhythmogenic effects of adrenaline 49 . Increased sympathetic activity may support right ventricular function in the setting of increased pulmonary vascular resistance, but such an effect is probably mitigated by high-dose opioids 50 .
Adverse cerebral effects
N 2 O is associated with a mismatch between cerebral metabolism and blood flow, and can increase intracranial pressure 51 . It is contraindicated for patients with severe head injury or expanding cerebral tumour, and many neuroanaesthetists no longer use N 2 O.
Lung atelectasis
Some anaesthetists are hesitant to remove N 2 O from the inspired gas mixture because a resultant high inspired oxygen fraction is thought to lead to atelectasis 52 . But there is theoretical evidence that coadministered N 2 O may promote collapse of poorly ventilated lung regions by gas absorption as effectively as does pure oxygen 53, 54 . These effects may be prevented if some nitrogen is included in the inspired gas mixture. Nevertheless, the clinical importance of absorption atelectasis in the pathogenesis of postoperative pulmonary collapse is unclear 55 . There does not appear to be a significant increase in arterial oxygen desaturation attributable to atelectasis in the postoperative period among patients receiving high inspired oxygen concentrations during surgery 52,53 .
Other
N 2 O is manufactured by the heating of ammonium nitrate, a potentially explosive process that has resulted on rare occasions in catastrophic industrial accidents. Impurities include such toxic compounds as ammonia, nitrogen dioxide, carbon monoxide and chlorine. N 2 O supports combustion. During laparoscopic surgery N 2 O can diffuse into the peritoneal cavity and, when mixed with bowel gas containing methane or hydrogen, attain sufficient concentration to create an explosion hazard 56 . Similar circumstances could occur during thoracoscopic surgery and tracheostomy. N 2 O depletes ozone, absorbs infrared radiation and so is a greenhouse gas 57, 58 . Despite anaesthesia being a minor source of greenhouse gas emissions, estimated to be less than 1% of global N 2 O production, the environmental consequences of continued worldwide use of N 2 O may not be negligible.
Beneficial Effects of N 2 O
N 2 O has been given to millions of patients since 1844 and the side-effects and safety profile are thought to be well-known. N 2 O was the first anaesthetic discovered and despite the introduction of many others, remains a mainstay of anaesthesia throughout the world 2 . The most notable advantage of N 2 O is that it allows a dose-reduction (in the order of 30-60%) of other more expensive and (possibly) more toxic anaesthetic drugs.
Long-standing safety record
When compared with other inhaled anaesthetics, N 2 O causes less cardiovascular and respiratory depression and may be associated with a lower incidence of intraoperative hypotension. It has less effect than some inhalational agents on cerebral haemodynamics. In addition, N 2 O is not associated with hepatotoxicity, nephrotoxicity or malignant hyperthermia. But because N 2 O is not a replacement for such agents (as it is only dose-sparing), it is unlikely that such rare events are prevented if N 2 O is used.
Analgesic
N 2 O produces dose-related analgesia in humans 1 , partly explaining its "MAC-sparing" properties of minimizing patient movement in response to pain. This effect may be mediated by the NMDA receptor 6, 37 . Intraoperative opioid doses therefore can be decreased, although its effect on postoperative opioid requirements is less clear.
Short-acting
N 2 O is relatively insoluble in body tissues, especially fat stores, compared with other inhalational agents, and so induction and recovery from anaesthesia theoretically may be achieved more rapidly. Interestingly, however, a recent large randomized controlled trial could not find a beneficial reduction in recovery times with N 2 O 58 . In this study, 1590 patients having gynaecological surgery under propofol anaesthesia were randomly allocated to N 2 O or N 2 O-free anaesthesia, and both groups had equivalent home readiness times 59 . Unfortunately this trial did not report rates of serious complications, and in view of the low-risk population, was unlikely to have sufficient power to detect an important clinical difference.
Reduced risk of awareness
Consciousness is lost at an end-tidal concentration of N 2 O of about 70% ("MAC-awake"), which is the usual concentration of N 2 O administered routinely. Even though N 2 O cannot be used as a sole agent, the addition of N 2 O to other agents is thought to protect against awareness. Tramer and co-workers 34 , in a systematic review of randomized trials including 2478 patients, reported a decreased risk of awareness with N 2 O. This finding may be challenged for its relevance to contemporary practice, as there is now widespread use of inhaled agent monitoring, better training and greater experience in total intravenous techniques, and the availability of monitors of hypnotic depth.
Conclusion
There are some compelling reasons to question the routine use of N 2 O 3 . Despite the fact that N 2 O was the first anaesthetic to be introduced, and is still widely used 2 , there is sufficient doubt as to its riskbenefit profile to justify a re-evaluation in contemporary anaesthetic practice. Level 1 evidence identifies exposure to N 2 O as a major risk factor in postoperative nausea and vomiting. It is clear that even brief exposure to N 2 O impairs methionine synthetase, DNA production, and red and white blood cell formation. This is most likely to be a problem with longer exposure. With increased potential for transient episodes of hypoxia, and a reduction in FiO 2 and P a O 2 , tissue hypoxia may be more common. These adverse effects are enhanced in high-risk patients and the elderly (i.e. those at highest risk for increased hospital length of stay and healthcare expenditure). The incidence of wound infection and cardiac morbidity attributable to N 2 O is not known. Large outcome trial data are lacking.
A major supporting argument for continued use of N 2 O is that it has been a key component of general anaesthesia throughout the modern era. Nearly all anaesthetists around the world have based their practice on including N 2 O as part of the inhaled gas mixture. To change practice would entail some retraining and additional experience, and may lead to a greater risk of awareness (if the resultant anaesthesia is too light) or delayed recovery (if the resultant anaesthesia is too deep). For those anaesthetists who are familiar with an N 2 O-free anaesthetic, such as those providing services for cardiac and neurosurgery, there may be little adjustment required. But for many, particularly those who have had a long time practice based on the inclusion of N 2 O, there will need to be a "recalibration" of how much additional volatile or intravenous hypnotic agent is needed. Such a change adds new demands to our practice. Another issue relates to cost. Exclusion of N 2 O from anaesthetic practice demands replacement with other agents, and drug acquisition costs can be expected to increase. However, if avoidance of N 2 O is associated with a reduction in complications and/or length of stay in the recovery room or hospital, then there would be a reduction in indirect costs. A formal cost-effectiveness analysis is required, and this needs good quality outcome data.
When considering the widespread use of N 2 O during anaesthesia in Australia and around the world, small differences in outcome would have major implications for healthcare delivery. A large randomized controlled trial is necessary to answer this question 60 . With the support of the Australian National Health and Medical Research Council, and the Australian and New Zealand College of Anaesthetists, our group has commenced a trial in 2,000 surgical patients: the ENIGMA Trial (Evaluation of Nitrous oxide In the Gas Mixture for Anaesthesia). Our primary endpoint is hospital length of stay; the major outcomes of the trial include wound infection, myocardial infarction, severe vomiting, quality of recovery, and thromboembolism. Results are expected to become available in 2006.
